{"id":429922,"date":"2020-04-30T17:42:29","date_gmt":"2020-04-30T21:42:29","guid":{"rendered":"http:\/\/www.rochester.edu\/newscenter\/?p=429922"},"modified":"2025-11-19T07:59:38","modified_gmt":"2025-11-19T12:59:38","slug":"remdesivir-promising-rochester-clinical-trial-429922","status":"publish","type":"post","link":"https:\/\/www.rochester.edu\/newscenter\/remdesivir-promising-rochester-clinical-trial-429922\/","title":{"rendered":"Remdesivir results \u2018promising\u2019 in Medical Center clinical trial"},"content":{"rendered":"
The Ä¢¹½´«Ã½<\/a> Medical Center has been participating in a clinical trial<\/a> testing the safety and efficacy of the antiviral drug remdesivir. According to preliminary results<\/a> released by the National Institutes of Health, the drug is now showing promise in treating adults diagnosed with COVID-19.\u00a0<\/span><\/p>\n The University\u2019s website<\/a> is a way to find guidance and critical information during a rapidly changing situation.<\/p>\n Find out what to do <\/a>if you or a close contact have symptoms or think you may have been exposed.<\/p>\n<\/div>\n The study is led by Ann Falsey<\/a>, a professor in the Department of Medicine (Infectious Diseases), and Angela Branche<\/a>, an assistant professor in the Department of Medicine (Infectious Diseases), with the Medical Center\u2019s Vaccine Treatment and Evaluation Unit (VTEU).\u00a0The Medical Center<\/a> is one of only nine VTEU sites in the US.<\/p>\n \u201cBased on some of the data that has come out in the last couple of days, it seems that remdesivir does show some proven benefit over placebo,\u201d Branche says.<\/p>\n Preliminary data from the trials indicate remdesivir speeds up recovery time for some patients with COVID-19. Specifically, the data show that patients who received remdesivir recovered, on average, four days faster than patients who received a placebo (11 days versus 14 days). The results also suggested a mortality rate of 8.0 percent for the group receiving remdesivir versus 11.6 percent for those in the placebo group. That result is considered promising but not statistically significant.<\/p>\n When Branche and Falsey told their teams about these preliminary results, \u201cone of our nurses said she\u2019s going to go home happy crying instead of sad crying, which I think is reflective of the magnitude of what we\u2019ve been seeing over the past months and how reassuring and rewarding it is to know we are part of something that could be beneficial to people,\u201d Branche says.<\/p>\nCoronavirus update<\/h2>\n
COVID-19 symptoms or exposure?<\/h2>\n